跳至主要内容
临床试验/ISRCTN14227980
ISRCTN14227980已完成2 期

Evaluation of the anti-arrhythmic effects of 3 oral dosages of S 44121 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction at risk for ventricular arrhythmia: a 12-week, randomised, double-blind, parallel-group, placebo controlled, international multicentre study

Institut de Recherches Internationales Servier (France)0 个研究点目标入组 149 人开始时间: 2010年5月21日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
149

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Both genders patients between 18 years or legal age and 80 years
  • 2. Symptomatic chronic heart failure for at least 6 months
  • 3. Ischaemic disease or idiopathic dilated cardiomyopathy as main cause for chronic heart failure

排除标准

  • 1. Women who are pregnant, breast-feeding or not using contraception
  • 2. Recent myocardial infarction, unstable angina or coronary revascularisation less than 3 months before selection
  • 3. History of stroke or cerebral transient ischemic attack within the previous 3 months before selection

研究者

发起方
Institut de Recherches Internationales Servier (France)

相似试验

已完成
2 期
Evaluation of the anti-arrhythmic effects of 3 oral dosages of S44121 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction at risk for ventricular arrhythmia. A 12-week, randomized, double-blind, parallel-group, placebo controlled, international multicentre study.failure of the heart pump function10019280
NL-OMON35783Servier R&D Benelux5
进行中(未招募)
1 期
Evaluation of the anti-arrhythmic effects of 3 oral dosages of S 44121 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction at risk for ventricular arrhythmia. A 12-week, randomized, double-blind, parallel-group, placebo controlled, international multicentre study.
EUCTR2009-014940-12-FRInstitut de Recherches Internationales Servier160
进行中(未招募)
1 期
Evaluation of the antiarrhythmic effects of 3 dosages of S 44121 versus placebo in patients with chronic heart failure at risk for ventricular arrhythmia.Chronic Heart Failure and left ventricular systolic dysfunction at risk for ventricular arrhythmiaMedDRA version: 14.1Level: PTClassification code 10049694Term: Left ventricular dysfunctionSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: PTClassification code 10007558Term: Cardiac failure chronicSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: PTClassification code 10047281Term: Ventricular arrhythmiaSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2009-014940-12-BEInstitut de Recherches Internationales Servier160
进行中(未招募)
1 期
Evaluation of the anti-arrhythmic effects of 3 oral dosages of S 44121 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction at risk for ventricular arrhythmia. A 12-week, randomized, double-blind, parallel-group, placebo controlled, international multicentre study.Chronic Heart Failure and left ventricular systolic dysfunction at risk for ventricular arrhythmiaMedDRA version: 12.1Level: LLTClassification code 10007558Term: Cardiac failure chronicMedDRA version: 12.1Level: LLTClassification code 10049694Term: Left ventricular dysfunctionMedDRA version: 12.1Level: LLTClassification code 10047281Term: Ventricular arrhythmia
EUCTR2009-014940-12-HUInstitut de Recherches Internationales Servier160
进行中(未招募)
不适用
Evaluation of the antiarrhythmic effects of 3 dosages of S 44121 versus placebo in patients with chronic heart failure at risk for ventricular arrhythmia.Chronic Heart Failure and left ventricular systolic dysfunction at risk for ventricular arrhythmiaMedDRA version: 14.1Level: PTClassification code 10049694Term: Left ventricular dysfunctionSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: PTClassification code 10007558Term: Cardiac failure chronicSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: PTClassification code 10047281Term: Ventricular arrhythmiaSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2009-014940-12-DEInstitut de Recherches Internationales Servier160